• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

整合素β1 在头颈部鳞状细胞癌中的干细胞标志物作用。

Role of integrin β1 as a biomarker of stemness in head and neck squamous cell carcinoma.

机构信息

Department of Otorhinolaryngology - Head and Neck Surgery, Research Institute of Medical Science, Konkuk University School of Medicine, Seoul, Republic of Korea.

Department of Otolaryngology - Head and Neck Surgery, Hallym University College of Medicine, Seoul, Republic of Korea.

出版信息

Oral Oncol. 2019 Sep;96:34-41. doi: 10.1016/j.oraloncology.2019.07.001. Epub 2019 Jul 4.

DOI:10.1016/j.oraloncology.2019.07.001
PMID:31422211
Abstract

OBJECTIVES

Signaling between cancer stem cells (CSC) and their extracellular matrix has a crucial role in CSC progression and maintenance. However, mediators of this signaling pathway in head and neck squamous cell carcinoma (HNSCC) are largely unknown. Here, we explored whether integrin β1, which is one of the key regulators of the communication between cells and their microenvironment, affected the stemness of HNSCC cells.

MATERIALS AND METHODS

We examined self-renewal capacity, chemoresistance, and xenograft tumorigenicity after knockdown of integrin β1 in primary HNSCC cells. In addition, we studied the role of focal adhesion kinase (FAK), an intracellular downstream molecule of integrin signaling, in influencing stemness of HNSCC. The relevance of Notch1 and integrin β1 interactions in HNSCC cells was also examined. Finally, immunohistochemical analysis was carried out to test whether the coexpression of integrin β1 and Notch1 in the samples from HNSCC patients correlated with their survival.

RESULTS

Targeting integrin β1 in HNSCC cells inhibited self-renewal, chemoresistance, and in vivo tumor-forming capacity. Treatment with an inhibitor of FAK decreased self-renewal capacities and expression of various putative stem cell markers (Oct4, Sox2, and Nanog) in a dose-dependent manner. Moreover, knockdown of integrin β1 decreased the expression of Notch1 and its target genes (Hey1 and Hes1). Notably, HNSCC patients demonstrating simultaneous expression of integrin β1 and Notch1 in their tissue samples had significantly worse survival rate.

CONCLUSION

Integrin β1/Notch1 axis has a significant role in the regulation of stemness in HNSCC.

摘要

目的

癌细胞干细胞(CSC)与其细胞外基质之间的信号传递在 CSC 的进展和维持中起着关键作用。然而,头颈部鳞状细胞癌(HNSCC)中这种信号通路的介质在很大程度上尚不清楚。在这里,我们探讨了整合素β1是否会影响 HNSCC 细胞的干性,整合素β1是细胞与其微环境之间通讯的关键调节剂之一。

材料和方法

我们在原代 HNSCC 细胞中敲低整合素β1后,检测了自我更新能力、化学抗性和异种移植肿瘤形成能力。此外,我们研究了整合素信号的细胞内下游分子粘着斑激酶(FAK)在影响 HNSCC 细胞干性中的作用。还研究了 Notch1 和整合素β1相互作用在 HNSCC 细胞中的相关性。最后,进行免疫组织化学分析以检测 HNSCC 患者样本中整合素β1和 Notch1的共表达是否与其生存相关。

结果

靶向 HNSCC 细胞中的整合素β1抑制了自我更新、化学抗性和体内肿瘤形成能力。FAK 抑制剂的处理以剂量依赖性方式降低了自我更新能力和各种假定的干细胞标志物(Oct4、Sox2 和 Nanog)的表达。此外,敲低整合素β1降低了 Notch1及其靶基因(Hey1 和 Hes1)的表达。值得注意的是,在组织样本中同时表达整合素β1和 Notch1的 HNSCC 患者的生存率显著降低。

结论

整合素β1/Notch1 轴在调节 HNSCC 中的干性方面起着重要作用。

相似文献

1
Role of integrin β1 as a biomarker of stemness in head and neck squamous cell carcinoma.整合素β1 在头颈部鳞状细胞癌中的干细胞标志物作用。
Oral Oncol. 2019 Sep;96:34-41. doi: 10.1016/j.oraloncology.2019.07.001. Epub 2019 Jul 4.
2
Notch1 signaling contributes to stemness in head and neck squamous cell carcinoma.Notch1信号传导对头颈部鳞状细胞癌的干性有促进作用。
Lab Invest. 2016 May;96(5):508-16. doi: 10.1038/labinvest.2015.163. Epub 2016 Feb 29.
3
Slug is a novel molecular target for head and neck squamous cell carcinoma stem-like cells.slug 是头颈部鳞状细胞癌干细胞的新型分子靶标。
Oral Oncol. 2020 Dec;111:104948. doi: 10.1016/j.oraloncology.2020.104948. Epub 2020 Aug 6.
4
Simultaneous β1 integrin-EGFR targeting and radiosensitization of human head and neck cancer.同时靶向整合素β1 和表皮生长因子受体并放射增敏人头颈癌细胞。
J Natl Cancer Inst. 2015 Feb 5;107(2). doi: 10.1093/jnci/dju419. Print 2015 Feb.
5
Involvement of c-Fos in the Promotion of Cancer Stem-like Cell Properties in Head and Neck Squamous Cell Carcinoma.c-Fos在促进头颈部鳞状细胞癌中癌干细胞样特性方面的作用。
Clin Cancer Res. 2017 Jun 15;23(12):3120-3128. doi: 10.1158/1078-0432.CCR-16-2811. Epub 2016 Dec 13.
6
Targeting HIF-1α/NOTCH1 pathway eliminates CD44 cancer stem-like cell phenotypes, malignancy, and resistance to therapy in head and neck squamous cell carcinoma.靶向 HIF-1α/NOTCH1 通路可消除头颈部鳞状细胞癌中 CD44 癌症干细胞样细胞表型、恶性肿瘤和对治疗的耐药性。
Oncogene. 2022 Feb;41(9):1352-1363. doi: 10.1038/s41388-021-02166-w. Epub 2022 Jan 10.
7
Integrin alpha 6 as a stemness driver is a novel promising target for HPV (+) head and neck squamous cell carcinoma.整合素α 6 作为干性驱动因子是 HPV(+)头颈部鳞状细胞癌的一个新的有前途的靶点。
Exp Cell Res. 2021 Oct 15;407(2):112815. doi: 10.1016/j.yexcr.2021.112815. Epub 2021 Sep 5.
8
The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma.Hippo 效应物 TAZ 通过转录激活头颈部鳞状细胞癌中的 SOX2 促进癌症干性。
Cell Death Dis. 2019 Aug 9;10(8):603. doi: 10.1038/s41419-019-1838-0.
9
C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.C-Met 通路促进头颈部鳞状细胞癌干细胞样细胞的自我更新和致瘤性。
Oral Oncol. 2014 Jul;50(7):633-9. doi: 10.1016/j.oraloncology.2014.04.004. Epub 2014 May 15.
10
Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.Wnt/β-catenin 信号通路通过激活 Oct4 来维持头颈部鳞状细胞癌干细胞样细胞的自我更新和致瘤性。
J Pathol. 2014 Sep;234(1):99-107. doi: 10.1002/path.4383. Epub 2014 Jul 23.

引用本文的文献

1
Integrins in cancer stem cells.癌症干细胞中的整合素
Front Cell Dev Biol. 2024 Aug 21;12:1434378. doi: 10.3389/fcell.2024.1434378. eCollection 2024.
2
Cancer stem cells: advances in knowledge and implications for cancer therapy.癌症干细胞:知识进展及其对癌症治疗的影响。
Signal Transduct Target Ther. 2024 Jul 5;9(1):170. doi: 10.1038/s41392-024-01851-y.
3
CD271 mRNA/hnRNPA2B1 complex promotes proliferation and stemness in oral and head and neck squamous cell carcinoma.CD271mRNA/hnRNPA2B1 复合物促进口腔和头颈部鳞状细胞癌的增殖和干性。
Cancer Sci. 2024 Jul;115(7):2346-2359. doi: 10.1111/cas.16187. Epub 2024 May 6.
4
Developments and future prospects of personalized medicine in head and neck squamous cell carcinoma diagnoses and treatments.头颈部鳞状细胞癌诊断与治疗中个性化医学的发展与展望。
Cancer Rep (Hoboken). 2024 Mar;7(3):e2045. doi: 10.1002/cnr2.2045.
5
Focal adhesion kinase: from biological functions to therapeutic strategies.粘着斑激酶:从生物学功能到治疗策略
Exp Hematol Oncol. 2023 Sep 25;12(1):83. doi: 10.1186/s40164-023-00446-7.
6
Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics.剖析并靶向癌症干细胞信号通路用于癌症治疗
Front Cell Dev Biol. 2023 May 25;11:1125174. doi: 10.3389/fcell.2023.1125174. eCollection 2023.
7
Claudin-4: A New Molecular Target for Epithelial Cancer Therapy.Claudin-4:上皮癌治疗的新分子靶点。
Int J Mol Sci. 2023 Mar 13;24(6):5494. doi: 10.3390/ijms24065494.
8
-Glycoproteomics Study of Putative -Glycoprotein Biomarkers of Drug Resistance in MCF-7/ADR Cells.MCF-7/ADR细胞中耐药相关假定糖蛋白生物标志物的糖蛋白质组学研究。
Phenomics. 2021 Oct 28;1(6):269-284. doi: 10.1007/s43657-021-00029-8. eCollection 2021 Dec.
9
Combination of Quercetin or/and siRNA-loaded DDAB-mPEG-PCL hybrid nanoparticles reverse resistance to Regorafenib in colon cancer cells.槲皮素或/和负载 siRNA 的 DDAB-mPEG-PCL 杂化纳米粒联合逆转结肠癌耐药细胞对瑞戈非尼的耐药性。
BMC Complement Med Ther. 2022 Dec 27;22(1):340. doi: 10.1186/s12906-022-03787-8.
10
Hypomethylation of Gene Promoter Is Associated with Malignant Phenotype in Urinary Bladder Cancer.基因启动子低甲基化与膀胱癌恶性表型相关。
Int J Mol Sci. 2022 Jun 10;23(12):6516. doi: 10.3390/ijms23126516.